Omeros Corp (NASDAQ:OMER)
| 5.07 Data as of Jun 19 |  -0.11 / -2.12%Today’s Change | 3.65 Today|||52-Week Range 13.45 | -2.31% Year-to-Date |
Latest OMER News | Press Releases
| OMER: Insiders Vs. Shorts Jun 19 / TheStreet.com |
Today’s Trading
| Previous close | 5.18 |
| Today’s open | 5.14 |
| Day’s range | -- - -- |
| Volume | 131,668 |
| Average volume (3 months) | 274,053 |
| Market cap | $154.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -23.26% |
| Earnings growth (this year) | +5.12% |
| Earnings growth (next 5 years) | +85.00% |
| Revenue growth (last year) | +33.11% |
| P/E ratio | NM |
| Price/Sales | 20.82 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OHRPOHR Pharmaceutical I... | +0.02 | +0.29% |
| POZNPOZEN Inc | -0.16 | -3.13% |
| FLMLFlamel Technologies ... | -0.02 | -0.32% |
| ARQLArQule Inc | -0.07 | -2.88% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $6.0M |
| Annual profit (last year) | -$38.4M |
| Net profit margin | -638.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President, CEO, CFO & Treasurer Gregory A. Demopulos, MD |
Chief Scientific Officer & Vice President George A. Gaitanaris, MD, PhD |
Corporate headquarters Seattle, Washington |
Forecasts
